Tosposertib phosphate

N/A

Report date: 2025/05/28 11:25:54

NME

Base Information

Drug NameTosposertib phosphate

Drug Alias NameTU-2218NCE401NCE-401

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionTransforming growth factor beta 2 inhibitorsTransforming growth factor beta receptor 1 inhibitorsVascular endothelial growth factor receptor 2 inhibitors

TargetsTransforming growth factor beta 2Transforming growth factor beta receptor 1Vascular endothelial growth factor receptor 2

Therapy Area/IndicationsSolid tumoursIdiopathic Pulmonary Fibrosis

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited StatesSouth Korea

CombinationsNo

Global Highest StatusPhase 2 Clinical

Highest Status in ChinaN/A

Originator CompaniesTiumBio Co Ltd

China Registration ClassN/A

Develop Information

Active CompaniesTiumBio Co Ltd

Inactive CompaniesN/A

Active IndicationsSolid tumoursIdiopathic Pulmonary Fibrosis

Inactive IndicationsN/A

Other Information

ATC CodeN/A